| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8780307 | Gynecologic Oncology | 2018 | 11 Pages |
Abstract
Chemical inhibition of the CBFβ/RUNX interaction is a viable strategy for the treatment of ovarian cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Anne L. Carlton, Anuradha Illendula, Yan Gao, Danielle C. Llaneza, Adam Boulton, Anant Shah, Roger A. Rajewski, Charles N. Landen, David Wotton, John H. Bushweller,